Vontobel Holding’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACRS
BCM
Vontobel Holding's ACRS Position: Q3 2026 in Review
Vontobel Holding increased its Aclaris Therapeutics (ACRS) stake by 4.4% in Q3 2026, buying an estimated $4.51K and bringing the position to 18,790 shares worth $98.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1423.
Vontobel Holding first reported a position in ACRS in Q1 2023 and has held it in 15 quarters since. The position peaked at $148K in Q2 2023. 167 funds tracked by Wall St. Rank hold ACRS as of Q3 2026.
- Vontobel Holding held 18,790 shares of Aclaris Therapeutics worth $98.8K as of Q3 2026.
- Vontobel Holding bought 790 Aclaris Therapeutics shares in Q3 2026, an estimated $4.51K.
- Aclaris Therapeutics made up ﹤0.01% of Vontobel Holding's portfolio in Q3 2026, its #1423 holding.
- Vontobel Holding first reported a position in Aclaris Therapeutics in Q1 2023 and has held it in 15 quarters since.
- Vontobel Holding's Aclaris Therapeutics position peaked at $148K in Q2 2023.
- 167 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q3 2026.
Based on Vontobel Holding's 13F filing for Q3 2026, filed 16 Oct 2026.